<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="groups in positions 2 and 6 have high cytotoxicity in" exact="cancer" post="cells HT-1080 (human lung fibrosarcoma) and MH-22A (mouse hepatoma),"/>
 <result pre="groups in positions 3 and 5 lack cytotoxicity in the" exact="cancer" post="cells HT-1080 and MH-22A even at high doses. Inclusion"/>
 <result pre="of ROS and the activity of scavenging/antioxidant enzymes in drug-resistant" exact="cancer" post="cells are typically increased compared to nonresistant cancer and"/>
 <result pre="in drug-resistant cancer cells are typically increased compared to nonresistant" exact="cancer" post="and normal cells. Thereby, multidrug-resistant (MDR) cancer cells may"/>
 <result pre="compared to nonresistant cancer and normal cells. Thereby, multidrug-resistant (MDR)" exact="cancer" post="cells may be more susceptible to alterations in ROS"/>
 <result pre="suggest that compounds modulating cellular ROS levels can enhance MDR" exact="cancer" post="cell death and sensitize MDR cancer cells to certain"/>
 <result pre="levels can enhance MDR cancer cell death and sensitize MDR" exact="cancer" post="cells to certain chemotherapeutic drugs [7]. It was concluded"/>
 <result pre="used for the modulation of cellular redox signaling. Lipids reveal" exact="cancer" post="cell-selective cytotoxicitiesâ€&quot;they are less cytotoxic in noncancerous healthy cells"/>
 <result pre="in positions 2 and 6 had very low cytotoxicity in" exact="cancer" post="cell lines HT-1080 and MH-22A and high calculated LD50"/>
 <result pre="were almost inert to the noncancerous cell line NIH3T3 and" exact="cancer" post="cell lines HT-1080 and MH-22A. This refers to several"/>
 <result pre="it was not possible to calculate IC50 values for the" exact="cancer" post="cell lines HT-1080 and MH-22A due to rather low"/>
 <result pre="2, comp. 13 versus comp. 4) showed significant cytotoxicity towards" exact="cancer" post="cell lines HT-1080 and MH-22A and still very low"/>
 <result pre="chain containing 1,4-DHP amphiphiles show promising dual activityâ€&quot;proliferation inhibition on" exact="cancer" post="cell lines and proliferation stimulating effect on normal cell"/>
 <result pre="nontoxic on noncancerous NIH3T3 cells and demonstrated selective cytotoxicity toward" exact="cancer" post="cells and pronounced cytotoxicity of around 3â€‰Î¼g/ml on HT-1080"/>
 <result pre="(comp. 22 versus comp. 10) leads to lower cytotoxicity to" exact="cancer" post="cell lines HT-1080 (10â€&quot;18â€‰Î¼g/ml versus 3â€‰Î¼g/ml) and MH-22A (10â€&quot;19â€‰Î¼g/ml"/>
 <result pre="1,4-DHP amphiphile 23, which has lower cytotoxicity to the studied" exact="cancer" post="and normal cell lines (comp. 23 versus comp. 10)â€&quot;a"/>
 <result pre="versus comp. 10)â€&quot;a cytotoxicity of around 47â€&quot;75â€‰Î¼g/ml versus 3â€&quot;6â€‰Î¼g/ml on" exact="cancer" post="cell lines and LD50 3448â€‰mg/kg versus 1482â€‰mg/kg, respectively. Further"/>
 <result pre="groups (comp. 24) leads to subsequent diminishing of cytotoxicity to" exact="cancer" post="cell lines (around 100â€‰Î¼g/ml) and also low calculated toxicity"/>
 <result pre="(comp. 25), the compounds revealed undetectable toxicity to the two" exact="cancer" post="cell lines and also low toxicity to the noncancerous"/>
 <result pre="showed that there are no significant changes of cytotoxicity in" exact="cancer" post="HT-1080 and MH-22A cells (5â€&quot;10â€‰Î¼g/ml versus 2â€&quot;4â€‰Î¼g/ml, and 29â€&quot;40â€‰Î¼g/ml"/>
 <result pre="gave a compound which was practically inert to the studied" exact="cancer" post="cell lines HT-1080 and MH-22A and was also nontoxic"/>
 <result pre="slightly lower anticancer activity of the compound towards the abovementioned" exact="cancer" post="cell lines and comparatively higher cytotoxicity to NIH3T3 cells"/>
 <result pre="gave compound 17 with less cytotoxicity (23â€&quot;54â€‰Î¼g/ml) on both tested" exact="cancer" post="cell lines and an LD50 value of 1274â€‰mg/kg, while"/>
 <result pre="decreased cytotoxicity of the target compound 26 in both tested" exact="cancer" post="HT-1080 and MH-22A cells (12â€&quot;27â€‰Î¼g/ml versus 3â€&quot;6â€‰Î¼g/ml, respectively) and"/>
 <result pre="of the molecule (comp. 28 and 29)â€&quot;were inert to tested" exact="cancer" post="cells HT-1080 and MH-22A and demonstrated high calculated LD50â€‰values"/>
 <result pre="24. Most dihydropyridone series cationic amphiphiles show marked cytotoxicity towards" exact="cancer" post="cells and medium cytotoxicity towards normal NIH3T3 cells: compounds"/>
 <result pre="and dihydropyridones as well as open-chain analogues: their cytotoxicity against" exact="cancer" post="cell lines HT-1080 and MH-22A in comparison with cytotoxicity"/>
 <result pre="groups in positions 3 and 5 demonstrated high cytotoxicity on" exact="cancer" post="cells HT-1080 and MH-22A, but low cytotoxicity on noncancerous"/>
 <result pre="for some of them, reversal of multidrug resistance in murine" exact="lymphoma" post="cells [16]. Together with antiradical activity, cell growth regulation,"/>
 <result pre="amphiphiles based on the 1,4-DHP core demonstrated high cytotoxicity in" exact="cancer" post="cells HT-1080 and MH-22A, but low cytotoxicity in the"/>
 <result pre="for the development of drug formulations to be used in" exact="cancer" post="treatment on the basis of these pleiotropic lipid-like 1,4-DHP"/>
 <result pre="and endosomal escapeNanomaterials201885p. 27010.3390/nano805027029695068 5HeK.TangM.Safety of novel liposomal drugs for" exact="cancer" post="treatment: advances and prospectsChemico-Biological Interactions2018295131910.1016/j.cbi.2017.09.00628919304 6MilkovicL.SiemsW.SiemsR.ZarkovicN.Oxidative stress and antioxidants"/>
 <result pre="in vitroMolecules2018237p. 154010.3390/molecules2307154029949910 16CindricM.CipakA.SerlyJ.et al.Reversal of multidrug resistance in murine" exact="lymphoma" post="cells by amphiphilic dihydropyridine antioxidant derivativeAnticancer Research201030104063406921036720 17DuburG.VÄ«ganteB.PlotnieceA.et al.Dihydropyridine"/>
</results>
